deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT01893632

Gabapentin Treatment of Benzodiazepine Dependence

Sponsor: New York State Psychiatric Institute

Conditions Benzodiazepine Dependence
Interventions Placebo gabapentin
Updated 14 times since 2017 Last updated: Apr 22, 2019 Started: Jul 31, 2013 Primary completion: Apr 1, 2016 Completion: Apr 1, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient recruitment, funding terminated from sponsor

Other terminated trials from New York State Psychiatric Institute

See all terminations from New York State Psychiatric Institute

Listed as NCT01893632, this PHASE2 trial focuses on Benzodiazepine Dependence and remains terminated or withdrawn. Sponsored by New York State Psychiatric Institute, it has been updated 14 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~May 2019 · 5 months · monthly snapshot~May 2019 – ~Jan 2021 · 20 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 9 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE2

  2. May 2019 — Jan 2021 [monthly]

    Terminated PHASE2

  3. Dec 2018 — May 2019 [monthly]

    Terminated PHASE2

  4. Sep 2018 — Dec 2018 [monthly]

    Terminated PHASE2

  5. Aug 2018 — Sep 2018 [monthly]

    Terminated PHASE2

  6. Jul 2018 — Aug 2018 [monthly]

    Terminated PHASE2

    Status: Unknown Status → Terminated

  7. Jun 2018 — Jul 2018 [monthly]

    Unknown Status PHASE2

  8. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

  9. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • New York State Psychiatric Institute
Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations